|
|
Session Topics & Chairs
The Program of the 37th NMCS will include the following Sessions:
- Integrating Novel Chemical Modalities in Hit-to-lead: a New Paradigm for Early Drug Discovery
Chair: Maria-Jesus Blanco (Atavistik Bio)
- New Directions in Targeting DNA Damage Repair (DDR)
Chairs: Erin DiMauro (Merck & Co. Inc.) and Srinivasa Karra (Avilar Therapeutics)
- Hot Targets from NYC Academic and Biotech Scene
Chairs: Robert DeVita (Icahn School of Medicine at Mt Sinai) and Amjad Ali (Merck & Co. Inc.)
- Targeting Autophagy for Cancer, Neurodegeneration, or Autoimmune Disease
Chairs: Erin DiMauro (Merck & Co. Inc.) and Hongjun Zhang (Cerevel Therapeutics, LLC.)
- Next Generation Therapies Shaped by Clinical Data
Chair: Matthew Volgraf (Septerna)
- Lessons from Drug Hunters across Academia, NPOs and the Pharmaceutical Industry
Chair: Phil Kym (AbbVie)
In addition, the Program will also feature an Award Session.
|
Organized by
Platinum Sponsor
Gold Sponsors
Silver Sponsors
Bronze Sponsors
Premium Exhibitors
|
